Modulation of ferroptosis by non ‑coding RNAs in cancers: Potential biomarkers for cancer diagnose and therapy

Pathol Res Pract. 2023 Dec 22;253:155042. doi: 10.1016/j.prp.2023.155042. Online ahead of print.ABSTRACTFerroptosis is a recently discovered cell programmed death. Extensive researches have indicated that ferroptosis plays an essential role in tumorigenesis, development, migration and chemotherapy drugs resistance, which makes it become a new target for tumor therapy. Non-coding RNAs (ncRNAs) are considered to control a wide range of cellular processes by modulating gene expression. Recent studies have indicated that ncRNAs regulate the process of ferroptosis via various pathway to affect the development of cancer. However, the regulation network remains ambiguous. In this review, we outlined the major metabolic processes of ferroptosis and concluded the relationship between ferroptosis-related ncRNAs and cancer progression. In addition, the prospect of ncRNAs being new therapeutic targets and early diagnosis biomarkers for cancer by regulating ferroptosis were presented, and the possible obstacles were also predicted. This could help in discovering novel cancer early diagnostic methods and therapeutic approaches.PMID:38184963 | DOI:10.1016/j.prp.2023.155042
Source: Pathology, Research and Practice - Category: Pathology Authors: Source Type: research